REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886FAD9.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $915,000 | -10.7% | 220,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,025,000 | -96.8% | 220,000 | -95.4% | 0.00% | -97.2% |
| Q4 2015 | $31,564,000 | +14.5% | 4,835,000 | -7.1% | 0.04% | +9.1% |
| Q3 2015 | $27,577,000 | +8.5% | 5,205,000 | +23.8% | 0.03% | +22.2% |
| Q2 2015 | $25,422,000 | – | 4,205,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 10,301,000 | $44,037,000 | 0.02% |
| Allianz Asset Management GmbH | 220,000 | $1,025,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,000 | $9,000 | 0.00% |